NCT04866043View on ClinicalTrials.gov

Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

October 15, 2021

Study Completion Date

October 15, 2021

Conditions
Binge-eating Disorder
Trial Locations (1)

2000

Site, Sydney

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT04866043 - Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder | Biotech Hunter | Biotech Hunter